Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Prostate|May 31, 2021
Clinical characteristics and oncological outcomes in negative multiparametric MRI patients undergoing robot-assisted radical prostatectomyVinayak G Wagaskar, Parita Ratnani, Micah Levy, et al.
Cancer Reports (Hoboken, N.J.)|March 4, 2021
A 4K score/MRI-based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancerVinayak G Wagaskar, Stanislaw Sobotka, Parita Ratnani, et al.
The Prostate|April 19, 2022
Prostate MRI percentage tumor involvement or "PI-RADS percent" as a predictor of adverse surgical pathologyParita Ratnani, Zach Dovey, Sneha Parekh, et al.
European Urology Open Science|February 6, 2023
Side-specific, Microultrasound-based Nomogram for the Prediction of Extracapsular Extension in Prostate CancerAdriana M Pedraza, Sneha Parekh, Himanshu Joshi, et al.
Cancer Reports (Hoboken, N.J.)|December 21, 2021
Unified model involving genomics, magnetic resonance imaging and prostate-specific antigen density outperforms individual co-variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancerAlp Tuna Beksac, Parita Ratnani, Zachary Dovey, et al.
European Urology Open Science|August 2, 2021
Clinical Utility of Negative Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer and Clinically Significant Prostate CancerVinayak G Wagaskar, Micah Levy, Parita Ratnani, et al.
Bladder Cancer (Amsterdam, Netherlands)|September 22, 2025
Genetic susceptibility and environmental risk factors in bladder cancer: Evidence from the UK biobankLaura Bukavina, Ilaha Isali, Sneha Parekh, et al.
World Journal of Urology|December 9, 2022
When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic levelUgo Giovanni Falagario, Dimple Chakravarty, Alberto Martini, et al.
Cancers|June 10, 2022
Association between Incidental Pelvic Inflammation and Aggressive Prostate CancerDimple Chakravarty, Parita Ratnani, Li Huang, et al.
European Urology Open Science|July 11, 2022
The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk CalculatorSneha Parekh, Parita Ratnani, Ugo Falagario, et al.
Pageof 3